Low Government Medical Expenditure Are Exploiting Taiwan s Doctors and Nurses - The News Lens International Edition thenewslens.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenewslens.com Daily Mail and Mail on Sunday newspapers.
EG12014, a biosimilar of the anti-HER2 monoclonal antibody trastuzumab, has received a marketing authorization from the European Commission for use in the European Union for the treatment of patients with HER2-positive breast and metastatic gastric cancer; these are the same indications that trastuzumab holds in the EU.
《TAIPEI TIMES》 50,000 people underpaid NT$732m in NHI premiums - 焦點 ltn.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ltn.com.tw Daily Mail and Mail on Sunday newspapers.